Skip to content
Medical Health Aged Care

ALERT: Leading Experts to Gather for 2nd International Sports and Cardiac Arrest Australia Symposium

Heart Foundation < 1 mins read

Wednesday 5 March 2025

Leading Experts to Gather for 2nd International Sports and Cardiac Arrest Australia Symposium

When: Friday, March 7 – Sunday, March 9, 2025
Where: Mantra Lorne, Victoria

Health and sports media are invited to cover the 2nd International Sports and Cardiac Arrest Australia Symposium, an essential event for medical professionals, researchers, and sports health specialists.

This three-day symposium will feature cutting-edge research, best practices, and collaborative discussions on sudden cardiac arrest in athletes and sports cardiology. Notably, in Australia, more than 26,000 people experience out-of-hospital cardiac arrests each year, with only about 10 per cent of people surviving.

Keynote speakers include:

  • Professor Eloi Marijon (France) – Head of the Lancet Commission on Sudden Cardiac Death Prevention.
  • Professor Michael Papadakis (UK) – President of the European Association of Preventive Cardiology.
  • Rob de Castella AO, MBE (Australia) – Marathon legend and Director of the Indigenous Marathon Foundation.

This event is hosted by the Australian Sudden Cardiac Arrest Alliance (AuSCAA) in partnership with the Heart Foundation.

ENDS


About us:

About AuSCAA 

AuSCAA is an expanding alliance of researchers, experts, and people with crucial lived experience whose mission is to prevent cardiac arrest and double survival rates in Australia


Contact details:


For media inquiries, interviews, or accreditation, please contact:

Shaun Inguanzo

M: 0404 769 054

E: [email protected]

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.